Plus Orthopedics No Longer Facing FDA “Application Integrity” Restrictions
This article was originally published in The Gray Sheet
Executive Summary
Smith & Nephew's new subsidiary Plus Orthopedics was removed from FDA's Application Integrity Policy (AIP) list Sept. 14 after three years of working with the agency to resolve its clinical trial issues